The time to first treatment and the probability of lymphocyte doubling-free survival depends on the EBV-DNA copy number in peripheral blood mononuclear cells (PBMCs) from chronic lymphocytic leukemia patients.
- Ewelina Grywalska (674942)
- Jacek Roliński (478916)
- Marcin Pasiarski (674941)
- Izabela Korona-Glowniak (674944)
- Maciej Maj (812491)
- Agata Surdacka (760120)
- Agnieszka Grafka (812492)
- Agnieszka Stelmach-Gołdyś (812493)
- Michał Zgurski (812494)
- Stanisław Góźdź (778173)
- Anna Malm (536813)
- Piotr Grabarczyk (242562)
- Elżbieta Starosławska (440321)
Publication date
October 2015
DOIAbstract
<p>(a) Kaplan-Meier curve illustrating the time to first treatment depending on the EBV-DNA copy number/μg DNA isolated from PBMCs; (b) Kaplan-Meier curve illustrating the probability of lymphocyte doubling-free survival depending on the EBV-DNA copy number/<i>μ</i>g DNA isolated from PBMCs.</p
Add to ORKG